000 01533 a2200409 4500
005 20250513175713.0
264 0 _c19990611
008 199906s 0 0 eng d
022 _a0160-2446
024 7 _a10.1097/00005344-199905000-00005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcVey, M J
245 0 0 _aCardiovascular pharmacology of the adenosine A1/A2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardium.
_h[electronic resource]
260 _bJournal of cardiovascular pharmacology
_cMay 1999
300 _a703-10 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCoronary Circulation
_xdrug effects
650 0 4 _aCoronary Disease
_xphysiopathology
650 0 4 _aDogs
650 0 4 _aHeart
_xdrug effects
650 0 4 _aImidazoles
_xpharmacology
650 0 4 _aIschemic Preconditioning, Myocardial
650 0 4 _aMyocardial Infarction
_xpathology
650 0 4 _aMyocardial Ischemia
_xpathology
650 0 4 _aMyocardial Reperfusion Injury
_xpathology
650 0 4 _aPurinergic P1 Receptor Agonists
650 0 4 _aPyridines
_xpharmacology
650 0 4 _aRegional Blood Flow
_xdrug effects
700 1 _aSmits, G J
700 1 _aCox, B F
700 1 _aKitzen, J M
700 1 _aClark, K L
700 1 _aPerrone, M H
773 0 _tJournal of cardiovascular pharmacology
_gvol. 33
_gno. 5
_gp. 703-10
856 4 0 _uhttps://doi.org/10.1097/00005344-199905000-00005
_zAvailable from publisher's website
999 _c10185974
_d10185974